Q2B26 Tokyo | Kenji Sugisaki, Hiroyuki Tezuka, and Yuhei Tachi; Deloitte Tohmatsu Group

Q2B26 Tokyo | Kenji Sugisaki, Hiroyuki Tezuka, and Yuhei Tachi; Deloitte Tohmatsu Group

🎙 Kenji Sugisaki, Hiroyuki Tezuka, Yuhei Tachi 👥 6K 📅 June 17, 2026 ⏱ 22 min 👁 118 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

quantum computinguse casesDeloittedrug discoveryindustry

Summary

The presentation by Deloitte Tohmatsu Group at Q2B26 Tokyo focuses on their initiatives in quantum technology. The speakers, Hiroyuki Tezuka, Kenji Sugisaki, and Yuhei Tachi, introduce themselves and their backgrounds, highlighting their transition from academia and industry to consulting. They emphasize Deloitte’s commitment to deep technology research, with a team of 50 quantum specialists and 700 members in the domain. They discuss the rapid progress in quantum computing, including error correction and algorithm improvements, which has accelerated the commercialization timeline to around 2030. They present their research results, including work on the HHL algorithm and QSCI method for quantum chemistry, and a joint demonstration with Chugai Pharmaceutical to estimate interaction energies in drug discovery using quantum computing. They highlight their unique approach of combining fundamental research with real-world applications and global collaborations. The talk concludes with an invitation to collaborate and visit their website.

144 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable insights into how a major consulting firm is positioning itself in the quantum computing space. The speakers argue that quantum computing is approaching an inflection point, with significant progress in error correction and algorithms, leading to an accelerated timeline for commercialization. They support this with examples of their own research and industry collaborations, such as the work on the HHL algorithm and the QSCI method, and the joint project with Chugai Pharmaceutical. The argumentation is coherent, but it relies heavily on their own claims without providing detailed evidence or external validation. The talk is more of an overview of their activities rather than a deep technical analysis, which limits its value for experts but makes it accessible to a broader audience.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate. The speakers mention their academic publications and a paper posted on arXiv, but they do not provide specific references or URLs during the talk. The title accurately reflects the content, as it features the three speakers and their affiliation. The presentation is based on their expertise and experience, but it lacks detailed citations or data to support their claims. The description includes a link to the Q2B conference website, but no direct sources are provided. Overall, the talk is informative but not highly rigorous in terms of sourcing.

233 words

Title / Content Match

The title accurately reflects the content, as it features the three speakers and their affiliation.

Quality & Reliability

7/10

The presentation is given by quantum scientists from Deloitte, with academic backgrounds and publications. They discuss their research and industry collaborations, but the talk is largely descriptive and lacks detailed technical depth. The claims about quantum progress are general and not backed by specific data in the talk.

Key Moments

Cited Sources

Concurring Sources

  • Q2B Conference Website — The event website, which may contain additional information about the conference and presentations.

Contribution & Novelties

The presentation offers a unique perspective from a consulting firm on the development of the quantum industry, emphasizing the importance of bridging fundamental research with commercial applications. It showcases specific use cases in drug discovery and highlights the need for resource estimation and algorithm optimization for early fault-tolerant quantum computers. The talk also underscores the role of global collaboration and industry partnerships in advancing quantum technology.

Pour aller plus loin :

108 words

Radar Profile

The radar profile shows moderate scores across all dimensions, with slightly higher scores in quality of information and reliability, reflecting the speakers' expertise. The lower score in technical level indicates that the presentation is not highly technical, making it accessible to a broader audience.

Reliability 7/10